ICCnotes

Inherited Cardiac Conditions reference

Open this condition in the interactive app →

Loeys-Dietz Syndrome

Quick Summary

Definition: An autosomal dominant connective tissue disorder of the TGF-β pathway, characterised by arterial tortuosity and aggressive, widespread arterial aneurysm and dissection.[1]

  • Prevalence: Rare (likely under-recognized) - MORE AGGRESSIVE than Marfan[3]
  • Key genes: TGFBR1, TGFBR2 (TGF-β pathway), SMAD3, autosomal dominant
  • Hallmark: Aortic aneurysm + hypertelorism + bifid uvula/cleft palate + arterial tortuosity (NO ectopia lentis)
  • High-risk markers: Dissection at smaller sizes (<42mm), younger age, rapid growth, family history dissection
  • First-line Mx: Beta-blockers, prophylactic surgery at 42mm (vs 50mm in Marfan), frequent imaging (6-12 monthly)

Aetiology

Monogenic (Mendelian): TGF-β pathway genes (TGFBR1/2, SMAD3, TGFB2/3)[1]

Genetics

Inheritance: Autosomal dominant; first-degree relatives have a 50% risk of inheriting the pathogenic variant.[1]

Familial vs de novo: Approximately 75% of cases are familial (inherited from an affected parent); approximately 25% arise as de novo mutations, no family history of LDS.[3]

Genes: TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3 (all TGF-β signalling pathway)

Penetrance: High but variable expressivity, even within the same family, severity of aortic involvement may differ significantly.

Prevalence

Estimated prevalence ~1 in 50,000–200,000; likely under-recognized due to phenotypic overlap with Marfan syndrome and other connective tissue disorders.[1]

Exact prevalence unknown; genetic confirmation has expanded the recognised spectrum since 2005.[3]

More aggressive than Marfan syndrome, aortic dissection occurs at smaller diameters and younger ages.

Diagnosis

Diagnosis is molecular: confirmed by a pathogenic variant in TGFBR1, TGFBR2, SMAD3, TGFB2 or TGFB3 (types 1–5) in a patient with arterial aneurysm/tortuosity or characteristic features. Gene-panel testing is mandatory and the specific gene guides the surgical threshold (most aggressive with TGFBR1/TGFBR2).[3] Baseline head-to-pelvis arterial imaging (CT/MRA) is required at diagnosis.[4]

Classic features (types 1-2):

  • Hypertelorism (widely spaced eyes)
  • Bifid uvula or cleft palate
  • Arterial tortuosity
  • Aortic root aneurysm

MORE AGGRESSIVE than Marfan: Dissection at smaller diameters, younger ages

Distinguish from Marfan: NO ectopia lentis, more craniofacial features, widespread arterial involvement

Investigations

CT/MR angiography: Head-to-pelvis, demonstrates widespread arterial tortuosity; mandatory at baseline and every 2–3 years[2]

Echo: Aortic root dimensions and mitral valve prolapse assessment[2]

Genetic testing: Multi-gene panel covering TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3[1]

Treatments

Medical therapy, reduce haemodynamic stress (same agents as Marfan; more aggressive targets[2]):

  • Beta-blockers (first-line):
    • Atenolol: start 25–50 mg once daily → target 50–100 mg once daily; target resting HR <60–65 bpm
    • Bisoprolol: start 2.5 mg once daily → 5–10 mg once daily
    • More aggressive HR targets than Marfan given higher dissection risk at smaller diameters
  • ARB, losartan (Grade IIa): Start 25–50 mg once daily → 100 mg once daily; target systolic BP <120–130 mmHg; beneficial for TGF-β pathway suppression
  • Avoid vigorous isometric exercise, contact sports; similar lifestyle restrictions as Marfan but STRICTER

Surgical intervention, LOWER threshold than Marfan:

  • Consider prophylactic surgery at aortic root ≥42–44 mm (vs 50 mm in Marfan)[2][4]
  • Some centres operate at ≥40 mm given unpredictable dissection at smaller diameters
  • Pan-arterial surveillance required, cervical, mesenteric, renal, iliac vessels also at risk

Monitoring:

  • Echo/CT/MRI every 6–12 months (more frequent than Marfan)
  • Full-body MRA at baseline and every 2–3 years (entire arterial tree)
Related Resources

Complications

  • Arterial aneurysm and dissection throughout the arterial tree: at smaller diameters and younger ages than Marfan[1]
  • Arterial tortuosity: with risk of organ and uterine rupture
  • High peripartum vascular risk.

Risk Stratification

Very high dissection risk even at smaller diameters

Pregnancy Management

PREGNANCY IN LOEYS-DIETZ SYNDROME - mWHO CLASS IV (CONTRAINDICATED)

MATERNAL MORTALITY RISK: 25-50%

PREGNANCY IS CONTRAINDICATED IN LOEYS-DIETZ SYNDROME

WHY PREGNANCY IS CONTRAINDICATED:

  • Unpredictable arterial dissection/rupture:
    • Can occur at ANY arterial diameter (including "normal" sizes <40mm)
    • Can affect ANY artery (aortic root, ascending/descending aorta, arch, head/neck vessels, visceral arteries, iliac arteries)
    • Pregnancy hormones (relaxin, progesterone) weaken already-fragile arterial walls
    • Volume expansion + increased cardiac output = increased wall stress
  • More aggressive than Marfan:
    • TGF-β signaling dysregulation → severe arterial fragility
    • Dissections occur at smaller diameters (aortic root 40-45mm vs >50mm in Marfan)
    • Younger age at dissection (mean age 26 vs 35-40 in Marfan)
  • Published outcomes catastrophic:
    • 25-50% maternal mortality in case series
    • Dissection during pregnancy, labour, or postpartum period
    • Even with prophylactic surgery pre-pregnancy: high residual risk (non-root dissections common)

PRECONCEPTION COUNSELLING - ESSENTIAL:

  • Counsel STRONGLY AGAINST pregnancy
    • Explain 25-50% maternal mortality risk clearly
    • Emphasize unpredictability of dissection (cannot reliably risk-stratify)
    • Discuss alternative family-building options: surrogacy (gestational carrier), adoption, child-free life
  • If patient insists on pregnancy despite counselling:
    • Document extensive counselling (informed consent regarding mortality risk)
    • Involve ethics committee/senior MDT
    • Full arterial tree imaging (CT/MR angiography head-to-pelvis)
    • Consider prophylactic aortic root repair if >42-44mm (though does NOT eliminate risk of non-root dissections)
    • Genetic counselling: 50% transmission risk to offspring
  • Contraception:
    • LARC strongly recommended (IUD, implant) - most reliable
    • Consider permanent sterilization if family complete
    • Male partner vasectomy option (safer than female tubal ligation surgery in LDS)

IF PREGNANCY OCCURS (unplanned or patient choice despite counselling):

  • Immediate actions:
    • Urgent specialist centre referral (tertiary aortopathy centre with cardiothoracic surgery)
    • Full arterial tree imaging (MR angiography - avoid CT radiation if possible, but do CT if MR unavailable)
    • Document all arterial dimensions (aortic root, ascending aorta, arch, descending, head/neck vessels, visceral, iliac)
    • MDT meeting (maternal-fetal medicine, cardiology, cardiothoracic surgery, genetics, anaesthetics, neonatology)
    • Offer termination of pregnancy given extreme maternal risk (document discussion)
  • If pregnancy continues - monitoring:
    • WEEKLY cardiology review throughout pregnancy
    • Echo EVERY 2 WEEKS (aortic root dimensions)
    • MR angiography each trimester (full arterial tree surveillance)
    • BP monitoring - target <120/80 mmHg (home BP monitoring)
    • Patient education: Report ANY pain immediately (chest, back, abdomen, neck, head)
  • Medical therapy:
    • Beta-blockers ESSENTIAL: Metoprolol 100-200mg/day OR atenolol 50-100mg/day
    • Target HR 60-70 bpm, BP <120/80 mmHg
    • ARBs/ACE-I contraindicated in pregnancy (teratogenic) despite potential vascular benefit
  • Activity restriction:
    • STRICT bed rest from viability onwards (some centres recommend from diagnosis)
    • No lifting, straining, Valsalva maneuvers
    • Minimize physical and emotional stress

DELIVERY PLANNING:

  • Timing:
    • Elective delivery at 32-34 weeks (balance fetal maturity vs maternal risk)
    • Earlier if ANY arterial growth or symptoms
    • Corticosteroids for fetal lung maturity at 32 weeks
  • Location:
    • Specialized tertiary aortopathy centre with on-site cardiothoracic surgery
    • ECMO capability
    • Level 3 NICU (for premature infant)
  • Mode of delivery:
    • Elective caesarean section under epidural/spinal - ONLY option
    • Vaginal delivery ABSOLUTELY CONTRAINDICATED (unpredictable labour, Valsalva with pushing, uncontrolled haemodynamics)
  • Anaesthesia:
    • Slowly-titrated epidural or combined spinal-epidural
    • Avoid general anaesthesia if possible (intubation = haemodynamic stress)
    • Arterial line (invasive BP monitoring)
    • Meticulous BP control: Systolic <110 mmHg, MAP <80 mmHg
  • Intraoperative monitoring:
    • Continuous ECG, pulse oximetry, capnography
    • Arterial line (beat-to-beat BP)
    • Large-bore IV access (dissection resuscitation readiness)
    • Cardiothoracic surgery team scrubbed/on standby
    • Blood products available (dissection protocol)

POSTPARTUM - EXTENDED HIGH-RISK PERIOD:

  • Critical first 12 weeks postpartum:
    • Dissection risk REMAINS VERY HIGH (unlike Marfan where risk drops after 6-8 weeks)
    • Hormonal changes, fluid shifts, physical stress continue to affect arteries
    • Many reported dissections occur weeks-to-months postpartum
  • Immediate postpartum (0-7 days):
    • ICU/HDU monitoring for 7 days minimum
    • Continuous BP monitoring (arterial line first 48-72 hours)
    • Daily clinical assessment for pain/symptoms
    • Continue beta-blockers (target BP <120/80, HR 60-70)
  • Outpatient monitoring (weeks 1-12):
    • WEEKLY cardiology review for 12 weeks
    • Echo every 2 weeks for 12 weeks
    • MR angiography at 6 weeks and 12 weeks postpartum
    • Home BP monitoring (patient to report if systolic >120 mmHg)
    • LOW THRESHOLD for urgent imaging if ANY symptoms (chest/back/abdominal/neck pain)
  • Medications:
    • Continue beta-blockers lifelong
    • Consider ARB (losartan) postpartum - emerging evidence for vascular protection in LDS
    • Breastfeeding: Compatible with metoprolol, atenolol; losartan limited data but likely acceptable
  • Permanent contraception:
    • STRONGLY RECOMMEND permanent contraception
    • Options: IUD (if refuses sterilization), bilateral tubal ligation at caesarean (surgery already high-risk, adding minimal extra risk), partner vasectomy (safest option - no surgical risk to patient)
    • Counsel extensively against any future pregnancy (risk does NOT decrease, may increase with age and arterial degeneration)

IF DISSECTION OCCURS:

  • During pregnancy:
    • Emergency caesarean delivery (if viable gestation)
    • Simultaneous or staged aortic repair (depends on location, maternal stability, gestation)
    • Type A dissection: Immediate surgery (cannot delay for fetal maturity)
    • Perimortem caesarean if maternal cardiac arrest
  • Postpartum:
    • Standard aortic dissection management (surgery for Type A, medical for Type B unless complications)
    • Even "successful" dissection repair = high maternal morbidity/mortality in LDS

SUMMARY - LOEYS-DIETZ SYNDROME PREGNANCY:

mWHO Class IV - CONTRAINDICATED
Maternal mortality: 25-50%

Dissection unpredictable, can occur at any arterial diameter, in any vessel, at any time during pregnancy or up to 12 weeks postpartum. More aggressive than Marfan syndrome.

COUNSEL AGAINST PREGNANCY. Offer alternative family-building options (surrogacy, adoption).

If pregnancy occurs: Weekly monitoring, deliver 32-34 weeks via elective CS at specialist centre, ICU monitoring for 7 days postpartum, weekly follow-up for 12 weeks, permanent contraception strongly recommended.

This is one of the highest-risk pregnancies in cardiology.

Follow-up

Based on ESC aortic-disease guidelines and Loeys-Dietz expert consensus[2][3][4].

Advanced / complicated = an aneurysm at or approaching the gene-specific surgical threshold, rapid growth, branch-vessel/arterial aneurysm, or prior dissection/repair.

Genotype-positive / phenotype-negative (G+/P−) = a confirmed pathogenic-variant carrier with no overt disease expression yet.

Genotype+ / Phenotype−Uncomplicated / StableAdvanced / Complicated
FrequencyEvery 6–12 months (from diagnosis)Every 6–12 monthsEvery 3–6 months
Clinical reviewSymptoms, strict BP controlSymptoms, BP control (strict)As above
Echocardiography (aortic root)6–12 monthlyEvery 6–12 months6-monthly or sooner
Head-to-pelvis CT / MR angiographyBaseline head-to-pelvis, then 1–2-yearly (extend if no distal disease)Baseline head-to-pelvis; interval individualised, toward 2-yearly if no distal/branch-vessel diseaseAnnual or sooner
Cervical / cerebral imagingBaselinePeriodic (arterial tortuosity, aneurysm)As indicated
PregnancyHigh-risk; pre-conception counsellingHigh-risk; pre-conception counselling essentialFrequent aortic imaging
Family screening–Cascade imaging + genetics–

Disclaimer: This table is general guidance based on published guidelines and does not replace clinical judgement. The responsible clinician is accountable for determining the appropriate, individualised follow-up plan for each patient.

Key Points

  • More aggressive than Marfan - lower surgical threshold (42-44mm vs 50mm)[1]
  • Image entire arterial tree - can dissect anywhere (head-to-pelvis CT/MR angiography)[1]
  • PREGNANCY mWHO CLASS IV - CONTRAINDICATED (25-50% maternal mortality risk)[1]
  • If pregnancy occurs: weekly monitoring, deliver 32-34 weeks, elective CS only, 12-week postpartum high-risk period
  • Permanent contraception strongly recommended - counsel against any future pregnancy

References & Review Date

Last reviewed: June 2026

  1. Loeys BL, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275–281. doi:10.1038/ng1541
  2. Erbel R, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35(41):2873–2926. doi:10.1093/eurheartj/ehu281
  3. MacCarrick G, et al. Loeys–Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014;16(8):576–587. doi:10.1038/gim.2014.11
  4. Mazzolai L, Teixido-Tura G, Lanzi S, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45:3538–3700. doi:10.1093/eurheartj/ehae179